2024 Lower Extremity Peripheral Artery Disease Guideline-at-a-Glance

Katie J. Bates,Mykela M. Moore,Morgane Cibotti-Sun

DOI: https://doi.org/10.1016/j.jacc.2024.04.003

IF: 24

2024-05-16

Journal of the American College of Cardiology

Abstract:Central Illustration Download : Download high-res image (1MB) Download : Download full-size image

cardiac & cardiovascular systems

What problem does this paper attempt to address?

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Heather L Gornik,Herbert D Aronow,Philip P Goodney,Shipra Arya,Luke Packard Brewster,Lori Byrd,Venita Chandra,Douglas E Drachman,Jennifer M Eaves,Jonathan K Ehrman,John N Evans,Thomas S D Getchius,J Antonio Gutiérrez,Beau M Hawkins,Connie N Hess,Karen J Ho,W Schuyler Jones,Esther S H Kim,Scott Kinlay,Lee Kirksey,Debra Kohlman-Trigoboff,Chandler A Long,Amy West Pollak,Saher S Sabri,Lawrence B Sadwin,Eric A Secemsky,Maya Serhal,Mehdi H Shishehbor,Diane Treat-Jacobson,Luke R Wilkins

DOI: https://doi.org/10.1161/CIR.0000000000001251

IF: 37.8

2024-06-11

Circulation

Abstract:Aim: The "2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease" provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia). Methods: A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate. Structure: Recommendations from the "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
2024 Hypertrophic Cardiomyopathy Guideline-at-a-Glance

Megan Coylewright,Morgane Cibotti-Sun,Mykela M. Moore

DOI: https://doi.org/10.1016/j.jacc.2024.04.002

IF: 24

2024-05-10

Journal of the American College of Cardiology

Abstract:Central Illustration Download : Download high-res image (922KB) Download : Download full-size image

cardiac & cardiovascular systems
2024 Guideline for Management of Wounds in Patients With Lower Extremity Arterial Disease

Phyllis A. Bonham,Linda R. Droste,Arturo González,Teresa J. Kelechi,Catherine R. Ratliff

DOI: https://doi.org/10.1097/won.0000000000001111

2024-09-01

Abstract:This article is an executive summary of the Wound, Ostomy, and Continence Nurses Society’s (WOCN) 2024 Guideline for Management of Wounds in Patients With Lower Extremity Arterial Disease. It is part of the Society’s Clinical Practice Guideline Series. This article presents an overview of the systematic process used to update and develop the guideline. It also lists specific recommendations from the guideline for screening and diagnosis, assessment, management, and education of patients with wounds due to lower extremity arterial disease (LEAD). Suggestions for implementing recommendations from the guideline are also summarized. The guideline is a resource for WOC nurse specialists, other nurses, and health care professionals who work with adults who have/or are at risk of wounds due to LEAD. The complete guideline includes the evidence and references supporting the recommendations, and it is available from the WOCN Society’s Bookstore (www.wocn.org). Refer to the Supplemental Digital Content Appendix (available at: http://links.lww.com/JWOCN/A123) associated with this article for a complete reference list for the guideline.

nursing
2024 Guideline for Management of Wounds in Patients With Lower Extremity Arterial Disease: An Executive Summary

Bonham,Phyllis A.; Droste,Linda R.; González,Arturo; Kelechi,Teresa J.; Ratliff,Catherine R.

DOI: https://doi.org/10.1097/won.0000000000001129

2024-09-25

Journal of Wound Ostomy and Continence Nursing

Abstract:This article is an executive summary of the Wound, Ostomy, and Continence Nurses Society's (WOCN) 2024 Guideline for Management of Wounds in Patients With Lower Extremity Arterial Disease. It is part of the Society's Clinical Practice Guideline Series. This article presents an overview of the systematic process used to update and develop the guideline. It also lists specific recommendations from the guideline for screening and diagnosis, assessment, management, and education of patients with wounds due to lower extremity arterial disease (LEAD). Suggestions for implementing recommendations from the guideline are also summarized. The guideline is a resource for WOC nurse specialists, other nurses, and health care professionals who work with adults who have/or are at risk of wounds due to LEAD. The complete guideline includes the evidence and references supporting the recommendations, and it is available from the WOCN Society's Bookstore ( www.wocn.org ). Refer to the Supplemental Digital Content Appendix (available at: https://links.lww.com/JWOCN/A123 ) associated with this article for a complete reference list for the guideline.

nursing
Drug-eluting devices for lower limb peripheral arterial disease

Yann Gouëffic,Marianne Brodmann,Koen Deloose,Maxime Dubosq-Lebaz,Joakim Nordanstig

DOI: https://doi.org/10.4244/EIJ-D-23-01080

2024-09-16

EuroIntervention

Abstract:Peripheral arterial disease is the third leading cause of cardiovascular morbidity after coronary artery disease and stroke. Lower limb peripheral arterial disease commonly involves infrainguinal arteries, may impair walking ability (intermittent claudication) and may confer a significant risk of limb loss (chronic limb-threatening ischaemia), depending on the severity of ischaemia. Endovascular treatment has become the mainstay revascularisation option in both the femoropopliteal and the below-the-knee arterial segments. After crossing and preparing the lesion, treatment results in these arterial segments can be enhanced by using drug-coated devices (drug-eluting stents and drug-coated balloons) that mitigate the occurrence of restenosis. As for other medical devices, the use of drug-eluting devices is based on their demonstrated safety and efficacy profiles when applied in the distinct segments of the lower limb vasculature. In this state-of-the-art narrative review we provide an overview of the safety and efficacy of drug-coated devices when used in the femoropopliteal and below-the-knee arterial segments.
A Practical Guide to Understanding and Treating Peripheral Artery Disease

Maya R Chilbert,Ashley E Woodruff,Kelly C Rogers,Maya R. Chilbert,Ashley E. Woodruff,Kelly C. Rogers

DOI: https://doi.org/10.1097/fjc.0000000000001556

IF: 3.271

2024-03-05

Journal of Cardiovascular Pharmacology

Abstract:Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic morbidity after coronary heart disease and stroke yet is widely underdiagnosed and undertreated. Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD. Patients should have adequate blood pressure and lipid control to decrease clinical manifestations and symptoms of PAD. Use of antithrombotic medications should be individualized to the patient depending on presence of symptoms, revascularization, and comorbidities. All patient care providers, including physicians, pharmacists, nurse practitioners, and physician assistants should incorporate PAD screening in their at-risk patients to improve access for appropriate earlier diagnosis, initiation of guideline directed therapy, and risk factor modification in order to reduce both major adverse CV and limb outcomes. The purpose of this narrative review is to provide an overview of PAD, summarize clinical trial evidence and guideline recommendations for screening and treatment in order to increase awareness among health care providers to ultimately have a positive impact on patient care.

pharmacology & pharmacy,cardiac & cardiovascular systems
Below-the-Knee Endovascular Revascularization

Jun Li,Ramon Varcoe,Marco Manzi,Steven Kum,Osamu Iida,Andrej Schmidt,Mehdi H Shishehbor,Mehdi H. Shishehbor

DOI: https://doi.org/10.1016/j.jcin.2023.11.040

2024-01-01

Abstract:Patients with chronic limb-threatening ischemia, the terminal stage of peripheral artery disease, are frequently afflicted by below-the-knee disease. Although all patients should receive guideline-directed medical therapy, restoration of inline flow is oftentimes necessary to avoid limb loss. Proper patient selection and proficiency in endovascular techniques for below-the-knee revascularization are intended to prevent major amputation and promote wound healing. This review, a consensus among an international panel of experienced operators, provides guidance on these challenges from an endovascular perspective and offers techniques to navigate this complex disease process.

cardiac & cardiovascular systems
New Horizons in Peripheral Artery Disease

John S M Houghton,Athanasios N Saratzis,Rob D Sayers,Victoria J Haunton

DOI: https://doi.org/10.1093/ageing/afae114

2024-06-01

Abstract:Peripheral artery disease (PAD) is the lower limb manifestation of systemic atherosclerotic disease. PAD may initially present with symptoms of intermittent claudication, whilst chronic limb-threatening ischaemia (CLTI), the end stage of PAD, presents with rest pain and/or tissue loss. PAD is an age-related condition present in over 10% of those aged ≥65 in high-income countries. Guidelines regarding definition, diagnosis and staging of PAD and CLTI have been updated to reflect the changing patterns and presentations of disease given the increasing prevalence of diabetes. Recent research has changed guidelines on optimal medical therapy, with low-dose anticoagulant plus aspirin recommended in some patients. Recently published randomised trials highlight where bypass-first or endovascular-first approaches may be optimal in infra-inguinal disease. New techniques in endovascular surgery have increased minimally invasive options for ever more complex disease. Increasing recognition has been given to the complexity of patients with CLTI where a high prevalence of both frailty and cognitive impairment are present and a significant burden of multi-morbidity and polypharmacy. Despite advances in minimally invasive revascularisation techniques and reduction in amputation incidence, survival remains poor for many with CLTI. Shared decision-making is essential, and conservative management is often appropriate for older patients. There is emerging evidence of the benefit of specialist geriatric team input in the perioperative management of older patients undergoing surgery for CLTI. Recent UK guidelines now recommend screening for frailty, cognitive impairment and delirium in older vascular surgery patients as well as recommending all vascular surgery services have support and input from specialist geriatrics teams.
Peripheral artery disease and outcomes: how can we improve risk prediction?

Mounica Yanamandala,Guillaume Goudot,Marie Denise Gerhard-Herman

DOI: https://doi.org/10.1093/eurheartj/ehae154

IF: 39.3

2024-04-13

European Heart Journal

Abstract:Graphical Open in new tabDownload slide Role of proposed measures in predicting major adverse limb events (MALE)

cardiac & cardiovascular systems
Lower extremity arterial disease in patients with diabetes: a contemporary narrative review

Mathilde Nativel,Louis Potier,Laure Alexandre,Laurence Baillet-Blanco,Eric Ducasse,Gilberto Velho,Michel Marre,Ronan Roussel,Vincent Rigalleau,Kamel Mohammedi

DOI: https://doi.org/10.1186/s12933-018-0781-1

IF: 8.949

2018-10-23

Cardiovascular Diabetology

Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Lower-extremity arterial disease (LEAD) is a major endemic disease with an alarming increased prevalence worldwide. It is a common and severe condition with excess risk of major cardiovascular events and death. It also leads to a high rate of lower-limb adverse events and non-traumatic amputation. The American Diabetes Association recommends a widespread medical history and clinical examination to screen for LEAD. The ankle brachial index (ABI) is the first non-invasive tool recommended to diagnose LEAD although its variable performance in patients with diabetes. The performance of ABI is particularly affected by the presence of peripheral neuropathy, medial arterial calcification, and incompressible arteries. There is no strong evidence today to support an alternative test for LEAD diagnosis in these conditions. The management of LEAD requires a strict control of cardiovascular risk factors including diabetes, hypertension, and dyslipidaemia. The benefit of intensive versus standard glucose control on the risk of LEAD has not been clearly established. Antihypertensive, lipid-lowering, and antiplatelet agents are obviously worthfull to reduce major cardiovascular adverse events, but few randomised controlled trials (RCTs) have evaluated the benefits of these treatments in terms of LEAD and its related adverse events. Smoking cessation, physical activity, supervised walking rehabilitation and healthy diet are also crucial in LEAD management. Several advances have been achieved in endovascular and surgical revascularization procedures, with obvious improvement in LEAD management. The revascularization strategy should take into account several factors including anatomical localizations of lesions, medical history of each patients and operator experience. Further studies, especially RCTs, are needed to evaluate the interest of different therapeutic strategies on the occurrence and progression of LEAD and its related adverse events in patients with diabetes.</p>

cardiac & cardiovascular systems,endocrinology & metabolism
Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

Vivienne Chuter,Frank Quigley,Patrik Tosenovsky,Jens Carsten Ritter,James Charles,Jane Cheney,Robert Fitridge,Stephen Twigg,Peter Lazzarini,Anita Raspovic,Jenny Prentice,Robert Commons,Robert Fitridge,James Charles,Jane Cheney,on behalf of the Australian Diabetes-related Foot Disease Guidelines & Pathways Project

DOI: https://doi.org/10.1186/s13047-022-00550-7

2022-07-05

Journal of Foot and Ankle Research

Abstract:Peripheral artery disease (PAD) is implicated in up to 50% of diabetes-related foot ulcers (DFU) and significantly contributes to morbidity and mortality in this population. An evidence-based guideline that is relevant to the national context including consideration of the unique geographical and health care system differences between Australia and other countries, and delivery of culturally safe care to First Nations people, is urgently required to improve outcomes for patients with PAD and DFU in Australia. We aimed to identify and adapt current international guidelines for diagnosis and management of patients with PAD and DFU to develop an updated Australian guideline.

orthopedics
ACR Appropriateness Criteria® Lower Extremity Chronic Venous Disease

Expert Panels on Interventional Radiology and Vascular Imaging,Paul J Rochon,Arun Reghunathan,Baljendra S Kapoor,Sanjeeva P Kalva,Nicholas Fidelman,Bill S Majdalany,Hani Abujudeh,Drew M Caplin,Jens Eldrup-Jorgensen,Khashayar Farsad,Marcelo S Guimaraes,Amit Gupta,Mikhail Higgins,A Tuba Kendi,Neil M Khilnani,Parag J Patel,Karin E Dill,Eric J Hohenwalter

DOI: https://doi.org/10.1016/j.jacr.2023.08.011

Abstract:Lower extremity venous insufficiency is a chronic medical condition resulting from primary valvular incompetence or, less commonly, prior deep venous thrombosis or extrinsic venous obstruction. Lower extremity chronic venous disease has a high prevalence with a related socioeconomic burden. In the United States, over 11 million males and 22 million females 40 to 80 years of age have varicose veins, with over 2 million adults having advanced chronic venous disease. The high cost to the health care system is related to the recurrent nature of venous ulcerative disease, with total treatment costs estimated >$2.5 billion per year in the United States, with at least 20,556 individuals with newly diagnosed venous ulcers yearly. Various diagnostic and treatment strategies are in place for lower extremity chronic venous disease and are discussed in this document. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Exercise therapy for chronic symptomatic peripheral artery disease

Lucia Mazzolai,Jill Belch,Maarit Venermo,Victor Aboyans,Marianne Brodmann,Alessandra Bura-Rivière,Sebastien Debus,Christine Espinola-Klein,Amy E Harwood,John A Hawley,Stefano Lanzi,Juraj Madarič,Guillaume Mahé,Davide Malatesta,Oliver Schlager,Arno Schmidt-Trucksäss,Chris Seenan,Henrik Sillesen,Garry A Tew,Adriana Visonà

DOI: https://doi.org/10.1093/eurheartj/ehad734

IF: 39.3

2024-03-10

European Heart Journal

Abstract:Abstract All guidelines worldwide strongly recommend exercise as a pillar of the management of patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy in this setting presents different modalities, and a structured programme provides optimal results. This clinical consensus paper is intended for clinicians to promote and assist for the set-up of comprehensive exercise programmes to best advice in patients with symptomatic chronic PAD. Different exercise training protocols specific for patients with PAD are presented. Data on patient assessment and outcome measures are narratively described based on the current best evidence. The document ends by highlighting disparities in access to supervised exercise programmes across Europe and the series of gaps for evidence requiring further research.

cardiac & cardiovascular systems
The significance of lower extremity peripheral arterial disease

Robert S. Dieter,William W. Chu,John P. Pacanowski,Patrick E. McBride,Timothy E. Tanke

DOI: https://doi.org/10.1002/clc.4950250103

2002-01-01

Clinical Cardiology

Abstract:The role of the cardiologist is expanding and involves the management of patients with lower extremity atherosclerotic occlusive arterial disease. Peripheral arterial disease (PAD) remains an underdiagnosed and undertreated disease. The purpose of this review is to educate the clinician on the significance of lower extremity atherosclerotic occlusive arterial disease. Pathophysiology and anatomy are briefly reviewed. The definition of PAD is based upon both anatomic and functional considerations. Risk factors for PAD include traditional atherosclerotic risk factors. There is a considerable overlap between coronary and cerebrovascular diseases and PAD. Diagnosis is made mainly by history and physical examination. Noninvasive and invasive tests help diagnosis and localize disease. Expanded therapies to improve outcomes include lifestyle changes, medical treatment, interventional cardiovascular procedures, or surgical intervention.

cardiac & cardiovascular systems
[Progress and prospect of the treatment of lower extremity arteriosclerosis obliterans].

X. T. Zheng,Y. H. Song

DOI: https://doi.org/10.3760/cma.j.cn112139-20200923-00453

2021-12-01

Abstract:In the past five years,both advancements and new problems were seen in the treatment of lower extremity arteriosclerosis obliterans.The Global Vascular Guidelines published in 2019 have given us comprehensive suggestions for the diagnosis and treatment of critical limb threatening ischemia(CLTI),but the grading and treatment suggestions for CLTI should be generalized.As to endovascular treatment,drug coated balloons have been found to be effective for limb salvage and graft patency in femoropopliteal and infra-popliteal artery occlusive diseases.As to surgical revascularization,persistent education and surveillance are necessary to maintain the practical quality of this fundamental technique.Inframalleolar bypass could achieve good graft patency and limb salvage rate for in CLTI patients.Regional anesthesia has been found to have lower risk than general anesthesia for lower extremity surgical revascularization.Percutaneous deep vein arterialization might be helpful for limb salvage in patients with non-option CLTI.A brief review about the treatment of lower extremity arteriosclerosis obliterans is performed based on latest literatures and institutional experience.Understanding the present situation and development trend is important for peripheral vascular practitioners.

Medicine
Prioritization of Treatments for Lower Extremity Peripheral Artery Disease in Low- and Middle-Income Countries

Gerald F. FOWKES,Rachel B. Forster,Carol E. Levin,Nadraj G. Naidoo,Ambuj Roy,Chang Shu,John Spertus,Kun Fang,Luis Bechara-Zamudio,Mariella Catalano,Adriana Visonà,Sigrid Nikol,John P. Fletcher,Michael R. Jaff,William R. Hiatt,Lars Norgren

DOI: https://doi.org/10.23736/s0392-9590.16.03716-0

2017-01-01

International Angiology

Abstract:Lower extremity peripheral artery disease (PAD) is increasing in prevalence in low- and middle-income countries creating a large health care burden. Clinical management may require substantial resources but little consideration has been given to which treatments are appropriate for less advantaged countries.The aim of this review was to systematically appraise published data on the costs and effectiveness of PAD treatments used commonly in high-income countries, and for an international consensus panel to review that information and propose a hierarchy of treatments relevant to low- and middle-income countries.Pharmacotherapy for intermittent claudication was found to be expensive and improve walking distance by a modest amount. Exercise and endovascular therapies were more effective and exercise the most cost-effective. For critical limb ischemia, bypass surgery and endovascular therapy, which are both resource intensive, resulted in similar rates of amputation-free survival. Substantial reductions in cardiovascular events occurred with use of low cost drugs (statins, ACE inhibitors, anti-platelets) and smoking cessation.The panel concluded that, in low- and middle-income countries, cardiovascular prevention is a top priority, whereas a lower priority should be given to pharmacotherapy for leg symptoms and revascularisation, except in countries with established vascular units.
Exercise Therapy for Peripheral Artery Disease

Thangada, Neela D.,McDermott, Mary M.

DOI: https://doi.org/10.1007/s11886-024-02043-4

IF: 3.955

2024-05-10

Current Cardiology Reports

Abstract:To summarize evidence regarding exercise treatments for lower extremity peripheral artery disease (PAD).

cardiac & cardiovascular systems
Outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease

Stephen D Adedokun,Maruf Sarwar,Keonmin Hwang,Aakash Hans,Janani Baskaran,Mahesh Anantha Narayanan

DOI: https://doi.org/10.23736/S0021-9509.23.12798-4

Abstract:Introduction: Peripheral arterial disease (PAD) is a progressive vascular condition characterized by the narrowing or blockage of arteries, primarily attributed to atherosclerosis. PAD's prevalence in the general population is estimated at approximately 5.9%. Notably however, among patients with chronic kidney disease (CKD), PAD's prevalence is substantially higher, ranging from 17% to 48%. This review paper emphasizes the pervasiveness of PAD and its intricate relationship with CKD and end-stage renal disease (ESRD). It demonstrates the importance of early detection, proactive screening, and understanding the formidable challenges associated with treating heavily calcified lesions. Evidence acquisition: Comprehensive literature searches encompassed the PubMed/MEDLINE, Cochrane Library, and Embase databases, in order to identify studies involving lower extremity peripheral arterial interventions in patients both with and without CKD or ESRD. The search spanned the timeframe from January 2001 to July 2023. The search strategy included vocabulary terms concerning peripheral artery disease, lower extremities, revascularization, chronic kidney disease, and end-stage renal disease. Evidence synthesis: Initial searches were used to identify articles based on title. Exclusion criteria was then applied, and any redundant articles were removed. The articles abstracts were then reviewed, and relevant articles were selected. Once selected the articles were thoroughly reviewed including the references to find other relevant articles that were missed during the initial search process. In total 28 articles were selected and included for review of clinical data in regard to PAD outcomes in patients with advanced kidney disease. Conclusions: The findings highlight the need for personalized approaches in diagnosing and treating PAD in CKD and ESRD patients. Interdisciplinary collaboration, such as those between nephrologists, vascular surgeons, and interventional radiologists, is vital to optimize outcomes. Further research should focus on innovative, tailored interventions to enhance limb preservation, reduce mortality, prolong patency, and cut healthcare costs.
In the Loop: Endovascular Pedal Arch Revascularization

Daniel Delgadillo,Tyler Liang,Mennatalla Hegazi,Nishant Sharma,Nii-Kabu Kabutey

DOI: https://doi.org/10.1016/j.avsg.2023.12.099

Abstract:Advanced endovascular techniques are increasingly being utilized to treat patients with peripheral arterial disease and chronic limb-threatening ischemia to improve lower extremity arterial perfusion. In diabetic patients, pedal arch patency has been associated with improved wound healing, limb salvage, and overall survival. Pedal-plantar loop revascularization is a technique that can restore arterial inflow between the dorsal and plantar arteries of the foot. This article will describe the inframallelolar arterial anatomy and focus on imaging, percutaneous endovascular techniques, and clinical study outcomes of pedal artery interventions.

2024 Lower Extremity Peripheral Artery Disease Guideline-at-a-Glance

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2024 Hypertrophic Cardiomyopathy Guideline-at-a-Glance

2024 Guideline for Management of Wounds in Patients With Lower Extremity Arterial Disease

2024 Guideline for Management of Wounds in Patients With Lower Extremity Arterial Disease: An Executive Summary

Drug-eluting devices for lower limb peripheral arterial disease

A Practical Guide to Understanding and Treating Peripheral Artery Disease

Below-the-Knee Endovascular Revascularization

New Horizons in Peripheral Artery Disease

Peripheral artery disease and outcomes: how can we improve risk prediction?

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review

Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

ACR Appropriateness Criteria® Lower Extremity Chronic Venous Disease

Exercise therapy for chronic symptomatic peripheral artery disease

The significance of lower extremity peripheral arterial disease

[Progress and prospect of the treatment of lower extremity arteriosclerosis obliterans].

Prioritization of Treatments for Lower Extremity Peripheral Artery Disease in Low- and Middle-Income Countries

Exercise Therapy for Peripheral Artery Disease

Outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease

In the Loop: Endovascular Pedal Arch Revascularization